Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ciliberto

Showing results (741-750 of 762) with videos related to

Pageof 77
Sort By:
Neurology|October 7, 2025
Factors Associated With More Medication Trials Before Surgical Evaluation and Postsurgical Outcomes in Pediatric Drug-Resistant EpilepsyDebopam Samanta, Grace Newell, Avery Robert Caraway, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 11, 2020
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER StudyGiulia Bon, Laura Pizzuti, Valentina Laquintana, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 21, 2021
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal modelsAntonella Conforti, Emanuele Marra, Fabio Palombo, et al.
Scientific Reports|July 3, 2021
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trialLaura Pizzuti, Maddalena Barba, Marco Mazzotta, et al.
Journal of Clinical Medicine|August 29, 2024
Obstetric Outcomes in Women on Lithium: A Systematic Review and Meta-AnalysisTommaso Callovini, Silvia Montanari, Francesca Bardi, et al.
Cancers|December 17, 2024
Tolerability and Preliminary Outcomes of Adjuvant T-DM1 in HER2-Positive Breast Cancer After Neoadjuvant Therapy: The ATD StudyEriseld Krasniqi, Lorena Filomeno, Teresa Arcuri, et al.
Journal for Immunotherapy of Cancer|May 23, 2019
Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshopDavide Bedognetti, Michele Ceccarelli, Lorenzo Galluzzi, et al.
World Journal of Psychiatry|July 10, 2024
This pain drives me crazy: Psychiatric symptoms in women with interstitial cystitis/bladder pain syndromeMarianna Mazza, Stella Margoni, Giuseppe Mandracchia, et al.
Journal of Cellular Physiology|December 12, 2018
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experienceLaura Pizzuti, Antonio Giordano, Andrea Michelotti, et al.
Journal of Inherited Metabolic Disease|July 19, 2020
Predominant and novel de novo variants in 29 individuals with ALG13 deficiency: Clinical description, biomarker status, biochemical analysis, and treatment suggestionsBobby G Ng, Erik A Eklund, Sergey A Shiryaev, et al.
Pageof 77

Showing results (741-750 of 762) with videos related to

Sort By:
Pageof 77
Neurology|October 7, 2025
Factors Associated With More Medication Trials Before Surgical Evaluation and Postsurgical Outcomes in Pediatric Drug-Resistant EpilepsyDebopam Samanta, Grace Newell, Avery Robert Caraway, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 11, 2020
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER StudyGiulia Bon, Laura Pizzuti, Valentina Laquintana, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 21, 2021
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal modelsAntonella Conforti, Emanuele Marra, Fabio Palombo, et al.
Scientific Reports|July 3, 2021
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trialLaura Pizzuti, Maddalena Barba, Marco Mazzotta, et al.
Journal of Clinical Medicine|August 29, 2024
Obstetric Outcomes in Women on Lithium: A Systematic Review and Meta-AnalysisTommaso Callovini, Silvia Montanari, Francesca Bardi, et al.
Cancers|December 17, 2024
Tolerability and Preliminary Outcomes of Adjuvant T-DM1 in HER2-Positive Breast Cancer After Neoadjuvant Therapy: The ATD StudyEriseld Krasniqi, Lorena Filomeno, Teresa Arcuri, et al.
Journal for Immunotherapy of Cancer|May 23, 2019
Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshopDavide Bedognetti, Michele Ceccarelli, Lorenzo Galluzzi, et al.
World Journal of Psychiatry|July 10, 2024
This pain drives me crazy: Psychiatric symptoms in women with interstitial cystitis/bladder pain syndromeMarianna Mazza, Stella Margoni, Giuseppe Mandracchia, et al.
Journal of Cellular Physiology|December 12, 2018
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experienceLaura Pizzuti, Antonio Giordano, Andrea Michelotti, et al.
Journal of Inherited Metabolic Disease|July 19, 2020
Predominant and novel de novo variants in 29 individuals with ALG13 deficiency: Clinical description, biomarker status, biochemical analysis, and treatment suggestionsBobby G Ng, Erik A Eklund, Sergey A Shiryaev, et al.
Pageof 77